ArticleJournal of the American College of Clinical Pharmacy : JACCP2024
Assessing pharmacy students' HIV pre-exposure prophylaxis (PrEP) prescribing knowledge, PrEP attitudes, and HIV-related stigma.
Article in Journal of the American College of Clinical Pharmacy : JACCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Introduction: Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) significantly reduces the risk of acquiring HIV. To increase PrEP prescribing, it is crucial to evaluate the preparedness of future pharmacists who will play a pivotal role in providing PrEP education, counseling, and prescribing. Objective: We assessed PrEP-prescribing knowledge, attitudes, and HIV-related stigma of pharmacy students. Methods: We conducted a cross-sectional web-based survey of student pharmacists in their final two years of education and training at the three University of California pharmacy schools. Survey questions assessed students' awareness of PrEP, familiarity with prescribing guidelines and Senate Bill 159 (SB159), PrEP knowledge, HIV-related stigma, and attitudes about PrEP. The sample was characterized using descriptive statistics, and non-parametric tests were used to examine associations between dependent variables and independent variables. A p-value <0.05 was deemed statistically significant. Results: A total of 110 students participated in the survey. The greatest familiarity with guidelines was observed in male (77.4%) ( Conclusion: Elevated HIV-related stigma, in the presence of high levels of PrEP knowledge, highlights the need to focus on destigmatizing HIV prevention services and increasing anti-stigma training, which is imperative in preparing student pharmacists to prescribe PrEP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.